202 related articles for article (PubMed ID: 27046792)
1. Characterization of cytoprotective and toxic properties of iron chelator SIH, prochelator BSIH and their degradation products.
Jansová H; Bureš J; Macháček M; Hašková P; Jirkovská A; Roh J; Wang Q; Franz KJ; Kovaříková P; Šimůnek T
Toxicology; 2016 Mar; 350-352():15-24. PubMed ID: 27046792
[TBL] [Abstract][Full Text] [Related]
2. LC-UV/MS methods for the analysis of prochelator-boronyl salicylaldehyde isonicotinoyl hydrazone (BSIH) and its active chelator salicylaldehyde isonicotinoyl hydrazone (SIH).
Bureš J; Jansová H; Stariat J; Filipský T; Mladěnka P; Šimůnek T; Kučera R; Klimeš J; Wang Q; Franz KJ; Kovaříková P
J Pharm Biomed Anal; 2015 Feb; 105():55-63. PubMed ID: 25527982
[TBL] [Abstract][Full Text] [Related]
3. Comparison of various iron chelators and prochelators as protective agents against cardiomyocyte oxidative injury.
Jansová H; Macháček M; Wang Q; Hašková P; Jirkovská A; Potůčková E; Kielar F; Franz KJ; Simůnek T
Free Radic Biol Med; 2014 Sep; 74():210-21. PubMed ID: 24992833
[TBL] [Abstract][Full Text] [Related]
4. Iron chelation with salicylaldehyde isonicotinoyl hydrazone protects against catecholamine autoxidation and cardiotoxicity.
Hašková P; Kovaříková P; Koubková L; Vávrová A; Macková E; Simůnek T
Free Radic Biol Med; 2011 Feb; 50(4):537-49. PubMed ID: 21147217
[TBL] [Abstract][Full Text] [Related]
5. Iron prochelator BSIH protects retinal pigment epithelial cells against cell death induced by hydrogen peroxide.
Charkoudian LK; Dentchev T; Lukinova N; Wolkow N; Dunaief JL; Franz KJ
J Inorg Biochem; 2008 Dec; 102(12):2130-5. PubMed ID: 18835041
[TBL] [Abstract][Full Text] [Related]
6. SIH--a novel lipophilic iron chelator--protects H9c2 cardiomyoblasts from oxidative stress-induced mitochondrial injury and cell death.
Simůnek T; Boer C; Bouwman RA; Vlasblom R; Versteilen AM; Sterba M; Gersl V; Hrdina R; Ponka P; de Lange JJ; Paulus WJ; Musters RJ
J Mol Cell Cardiol; 2005 Aug; 39(2):345-54. PubMed ID: 15978614
[TBL] [Abstract][Full Text] [Related]
7. 2,6-Dihydroxybenzaldehyde Analogues of the Iron Chelator Salicylaldehyde Isonicotinoyl Hydrazone: Increased Hydrolytic Stability and Cytoprotective Activity against Oxidative Stress.
Jansová H; Kubeš J; Reimerová P; Štěrbová-Kovaříková P; Roh J; Šimůnek T
Chem Res Toxicol; 2018 Nov; 31(11):1151-1163. PubMed ID: 30395451
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of novel salicylaldehyde isonicotinoyl hydrazone (SIH) analogs: iron chelation, anti-oxidant and cytotoxic properties.
Potůčková E; Hrušková K; Bureš J; Kovaříková P; Špirková IA; Pravdíková K; Kolbabová L; Hergeselová T; Hašková P; Jansová H; Macháček M; Jirkovská A; Richardson V; Lane DJ; Kalinowski DS; Richardson DR; Vávrová K; Šimůnek T
PLoS One; 2014; 9(11):e112059. PubMed ID: 25393531
[TBL] [Abstract][Full Text] [Related]
9. Prooxidant and antioxidant properties of salicylaldehyde isonicotinoyl hydrazone iron chelators in HepG2 cells.
Caro AA; Commissariat A; Dunn C; Kim H; García SL; Smith A; Strang H; Stuppy J; Desrochers LP; Goodwin TE
Biochim Biophys Acta; 2015 Nov; 1850(11):2256-64. PubMed ID: 26275495
[TBL] [Abstract][Full Text] [Related]
10. The hydrolytic susceptibility of prochelator BSIH in aqueous solutions.
Wang Q; Franz KJ
Bioorg Med Chem Lett; 2017 Sep; 27(17):4165-4170. PubMed ID: 28734582
[TBL] [Abstract][Full Text] [Related]
11. A pro-chelator triggered by hydrogen peroxide inhibits iron-promoted hydroxyl radical formation.
Charkoudian LK; Pham DM; Franz KJ
J Am Chem Soc; 2006 Sep; 128(38):12424-5. PubMed ID: 16984186
[TBL] [Abstract][Full Text] [Related]
12. Iron chelation protects the retinal pigment epithelial cell line ARPE-19 against cell death triggered by diverse stimuli.
Lukinova N; Iacovelli J; Dentchev T; Wolkow N; Hunter A; Amado D; Ying GS; Sparrow JR; Dunaief JL
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1440-7. PubMed ID: 19182262
[TBL] [Abstract][Full Text] [Related]
13. Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone.
Simůnek T; Sterba M; Popelová O; Kaiserová H; Adamcová M; Hroch M; Hasková P; Ponka P; Gersl V
Br J Pharmacol; 2008 Sep; 155(1):138-48. PubMed ID: 18536744
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotective effects of iron chelator HAPI and ROS-activated boronate prochelator BHAPI against catecholamine-induced oxidative cellular injury.
Hašková P; Jansová H; Bureš J; Macháček M; Jirkovská A; Franz KJ; Kovaříková P; Šimůnek T
Toxicology; 2016 Sep; 371():17-28. PubMed ID: 27744045
[TBL] [Abstract][Full Text] [Related]
15. Methyl and ethyl ketone analogs of salicylaldehyde isonicotinoyl hydrazone: novel iron chelators with selective antiproliferative action.
Macková E; Hrušková K; Bendová P; Vávrová A; Jansová H; Hašková P; Kovaříková P; Vávrová K; Simůnek T
Chem Biol Interact; 2012 May; 197(2-3):69-79. PubMed ID: 22521999
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and initial in vitro evaluations of novel antioxidant aroylhydrazone iron chelators with increased stability against plasma hydrolysis.
Hruskova K; Kovarikova P; Bendova P; Haskova P; Mackova E; Stariat J; Vavrova A; Vavrova K; Simunek T
Chem Res Toxicol; 2011 Mar; 24(3):290-302. PubMed ID: 21214215
[TBL] [Abstract][Full Text] [Related]
17. Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: a study of salicylaldehyde isonicotinoyl hydrazone (SIH).
Sterba M; Popelová O; Simůnek T; Mazurová Y; Potácová A; Adamcová M; Guncová I; Kaiserová H; Palicka V; Ponka P; Gersl V
Toxicology; 2007 Jun; 235(3):150-66. PubMed ID: 17459556
[TBL] [Abstract][Full Text] [Related]
18. The antioxidant effects of a novel iron chelator salicylaldehyde isonicotinoyl hydrazone in the prevention of H(2)O(2) injury in adult cardiomyocytes.
Horackova M; Ponka P; Byczko Z
Cardiovasc Res; 2000 Aug; 47(3):529-36. PubMed ID: 10963725
[TBL] [Abstract][Full Text] [Related]
19. Examination of diverse iron-chelating agents for the protection of differentiated PC12 cells against oxidative injury induced by 6-hydroxydopamine and dopamine.
Hašková P; Applová L; Jansová H; Homola P; Franz KJ; Vávrová K; Roh J; Šimůnek T
Sci Rep; 2022 Jun; 12(1):9765. PubMed ID: 35697900
[TBL] [Abstract][Full Text] [Related]
20. Modifying aroylhydrazone prochelators for hydrolytic stability and improved cytoprotection against oxidative stress.
Wang Q; Franz KJ
Bioorg Med Chem; 2018 Dec; 26(22):5962-5972. PubMed ID: 30429096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
